

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.32845294 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.21066784 |
| 3 | protein localization to endosome (GO:0036010) | 3.91684804 |
| 4 | mannose metabolic process (GO:0006013) | 3.84378518 |
| 5 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.79564304 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 3.70911251 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 3.70911251 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.70911251 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.70911251 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.70911251 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.70911251 |
| 12 | locomotory exploration behavior (GO:0035641) | 3.69735246 |
| 13 | gamma-aminobutyric acid transport (GO:0015812) | 3.65698597 |
| 14 | synaptic vesicle maturation (GO:0016188) | 3.65606740 |
| 15 | sodium ion export (GO:0071436) | 3.64782381 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.61080273 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.61080273 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.56797174 |
| 19 | barbed-end actin filament capping (GO:0051016) | 3.55707177 |
| 20 | response to peptidoglycan (GO:0032494) | 3.54955799 |
| 21 | regulation of cholesterol homeostasis (GO:2000188) | 3.50122704 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.45840060 |
| 23 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.44301551 |
| 24 | glutamate secretion (GO:0014047) | 3.42588172 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 3.39307354 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.37122836 |
| 27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.35537080 |
| 28 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.32785729 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.29179652 |
| 30 | detection of other organism (GO:0098543) | 3.27849889 |
| 31 | proline transport (GO:0015824) | 3.26575052 |
| 32 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.23722271 |
| 33 | phosphate ion transmembrane transport (GO:0035435) | 3.21067470 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.20430933 |
| 35 | cellular potassium ion homeostasis (GO:0030007) | 3.20236127 |
| 36 | detection of bacterium (GO:0016045) | 3.19203089 |
| 37 | phosphate ion transport (GO:0006817) | 3.17662124 |
| 38 | histone H3-K4 trimethylation (GO:0080182) | 3.14260040 |
| 39 | regulation of leukocyte degranulation (GO:0043300) | 3.14152930 |
| 40 | regulation of gene silencing by RNA (GO:0060966) | 3.12202656 |
| 41 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.12202656 |
| 42 | regulation of gene silencing by miRNA (GO:0060964) | 3.12202656 |
| 43 | response to muramyl dipeptide (GO:0032495) | 3.11727848 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.10090722 |
| 45 | vocalization behavior (GO:0071625) | 3.10051872 |
| 46 | glycine transport (GO:0015816) | 3.09999243 |
| 47 | stress fiber assembly (GO:0043149) | 3.09031115 |
| 48 | anterior/posterior axis specification, embryo (GO:0008595) | 3.07769742 |
| 49 | pre-miRNA processing (GO:0031054) | 3.04976590 |
| 50 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.04041694 |
| 51 | neurotransmitter secretion (GO:0007269) | 3.02056590 |
| 52 | determination of adult lifespan (GO:0008340) | 3.00335058 |
| 53 | pinocytosis (GO:0006907) | 2.99618553 |
| 54 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.98248958 |
| 55 | response to laminar fluid shear stress (GO:0034616) | 2.97471711 |
| 56 | alanine transport (GO:0032328) | 2.97223940 |
| 57 | regulation of hippo signaling (GO:0035330) | 2.96115854 |
| 58 | regulation of early endosome to late endosome transport (GO:2000641) | 2.95145512 |
| 59 | neuromuscular process controlling balance (GO:0050885) | 2.94960050 |
| 60 | glutamate metabolic process (GO:0006536) | 2.92722843 |
| 61 | detection of external biotic stimulus (GO:0098581) | 2.84661956 |
| 62 | presynaptic membrane organization (GO:0097090) | 2.83267296 |
| 63 | cellular extravasation (GO:0045123) | 2.82186934 |
| 64 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.81500129 |
| 65 | exploration behavior (GO:0035640) | 2.80294866 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 2.80228701 |
| 67 | ethanol oxidation (GO:0006069) | 2.78679421 |
| 68 | macroautophagy (GO:0016236) | 2.77316335 |
| 69 | vesicle transport along microtubule (GO:0047496) | 2.77060049 |
| 70 | modulation by symbiont of host cellular process (GO:0044068) | 2.76860638 |
| 71 | phospholipid homeostasis (GO:0055091) | 2.76532808 |
| 72 | positive regulation of receptor recycling (GO:0001921) | 2.75343120 |
| 73 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.74293777 |
| 74 | L-amino acid import (GO:0043092) | 2.74267638 |
| 75 | synaptic vesicle endocytosis (GO:0048488) | 2.69979474 |
| 76 | detection of molecule of bacterial origin (GO:0032490) | 2.69443223 |
| 77 | histone H3-K9 demethylation (GO:0033169) | 2.69173154 |
| 78 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68648473 |
| 79 | regulation of protein polyubiquitination (GO:1902914) | 2.67978623 |
| 80 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.66384028 |
| 81 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.65629571 |
| 82 | germinal center formation (GO:0002467) | 2.65444757 |
| 83 | positive thymic T cell selection (GO:0045059) | 2.64665987 |
| 84 | negative regulation of interleukin-12 production (GO:0032695) | 2.63765687 |
| 85 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.63762613 |
| 86 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.62196983 |
| 87 | positive regulation of synapse maturation (GO:0090129) | 2.62150576 |
| 88 | leukocyte aggregation (GO:0070486) | 2.61848256 |
| 89 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.61071033 |
| 90 | regulation of extracellular matrix disassembly (GO:0010715) | 2.60712077 |
| 91 | regulation of regulated secretory pathway (GO:1903305) | 2.60101412 |
| 92 | apoptotic cell clearance (GO:0043277) | 2.58275644 |
| 93 | histone H3-K36 demethylation (GO:0070544) | 2.57393751 |
| 94 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.56028746 |
| 95 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.55870202 |
| 96 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.55277070 |
| 97 | cortical actin cytoskeleton organization (GO:0030866) | 2.54773449 |
| 98 | neuromuscular process controlling posture (GO:0050884) | 2.54408674 |
| 99 | drug catabolic process (GO:0042737) | 2.53459714 |
| 100 | cell-substrate junction assembly (GO:0007044) | 2.52233626 |
| 101 | neurotransmitter transport (GO:0006836) | 2.51986842 |
| 102 | detection of biotic stimulus (GO:0009595) | 2.50794035 |
| 103 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.50575576 |
| 104 | modulation by virus of host process (GO:0019054) | 2.50309776 |
| 105 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.50178262 |
| 106 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.49355510 |
| 107 | NIK/NF-kappaB signaling (GO:0038061) | 2.49240132 |
| 108 | regulation of gamma-delta T cell activation (GO:0046643) | 2.48867198 |
| 109 | cell-cell junction maintenance (GO:0045217) | 2.47955592 |
| 110 | cysteine metabolic process (GO:0006534) | 2.47933815 |
| 111 | signal complex assembly (GO:0007172) | 2.46598021 |
| 112 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.46495346 |
| 113 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.46408391 |
| 114 | cell migration in hindbrain (GO:0021535) | 2.45137722 |
| 115 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.44263770 |
| 116 | cell junction maintenance (GO:0034331) | 2.43955152 |
| 117 | synaptic vesicle exocytosis (GO:0016079) | 2.43320039 |
| 118 | exogenous drug catabolic process (GO:0042738) | 2.43135815 |
| 119 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.42859409 |
| 120 | sulfur amino acid catabolic process (GO:0000098) | 2.42567598 |
| 121 | positive regulation of leukocyte degranulation (GO:0043302) | 2.41924484 |
| 122 | immunoglobulin mediated immune response (GO:0016064) | 2.41168274 |
| 123 | filopodium assembly (GO:0046847) | 2.39902797 |
| 124 | regulation of translational termination (GO:0006449) | 2.39286747 |
| 125 | organelle transport along microtubule (GO:0072384) | 2.39270405 |
| 126 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.38627696 |
| 127 | regulation of defense response to virus by virus (GO:0050690) | 2.38042596 |
| 128 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.37414419 |
| 129 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.37371934 |
| 130 | response to host (GO:0075136) | 2.37371934 |
| 131 | response to host defenses (GO:0052200) | 2.37371934 |
| 132 | activation of Rac GTPase activity (GO:0032863) | 2.37303695 |
| 133 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.36944473 |
| 134 | negative regulation of hormone metabolic process (GO:0032351) | 2.36944473 |
| 135 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.36808498 |
| 136 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.36526337 |
| 137 | thymic T cell selection (GO:0045061) | 2.36441955 |
| 138 | glycosphingolipid catabolic process (GO:0046479) | 2.35664979 |
| 139 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.35334180 |
| 140 | regulation of macrophage cytokine production (GO:0010935) | 2.35156044 |
| 141 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.35017585 |
| 142 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.35017585 |
| 143 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.35017585 |
| 144 | regulation of neurotransmitter levels (GO:0001505) | 2.34472114 |
| 145 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.33787720 |
| 146 | receptor recycling (GO:0001881) | 2.33714101 |
| 147 | peptide catabolic process (GO:0043171) | 2.33485502 |
| 148 | synaptic transmission, glutamatergic (GO:0035249) | 2.33432881 |
| 149 | Golgi transport vesicle coating (GO:0048200) | 2.33259717 |
| 150 | COPI coating of Golgi vesicle (GO:0048205) | 2.33259717 |
| 151 | apoptotic process involved in morphogenesis (GO:0060561) | 2.33113813 |
| 152 | cellular modified amino acid catabolic process (GO:0042219) | 2.33024396 |
| 153 | regulation of ARF GTPase activity (GO:0032312) | 2.32930817 |
| 154 | embryonic process involved in female pregnancy (GO:0060136) | 2.32772363 |
| 155 | amino acid import (GO:0043090) | 2.32345025 |
| 156 | semaphorin-plexin signaling pathway (GO:0071526) | 2.32198556 |
| 157 | regulation of ARF protein signal transduction (GO:0032012) | 2.31675300 |
| 158 | L-phenylalanine catabolic process (GO:0006559) | 2.31545509 |
| 159 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.31545509 |
| 160 | regulation of synapse maturation (GO:0090128) | 2.30776480 |
| 161 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.30379093 |
| 162 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.30354568 |
| 163 | response to host immune response (GO:0052572) | 2.30354568 |
| 164 | hemidesmosome assembly (GO:0031581) | 2.30328624 |
| 165 | C4-dicarboxylate transport (GO:0015740) | 2.30323710 |
| 166 | cell-substrate adherens junction assembly (GO:0007045) | 2.30236012 |
| 167 | focal adhesion assembly (GO:0048041) | 2.30236012 |
| 168 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.30083400 |
| 169 | vitamin transmembrane transport (GO:0035461) | 2.29750260 |
| 170 | glutamine family amino acid catabolic process (GO:0009065) | 2.28848100 |
| 171 | adherens junction assembly (GO:0034333) | 2.28681373 |
| 172 | neutral amino acid transport (GO:0015804) | 2.28500081 |
| 173 | cellular response to ammonium ion (GO:0071242) | 2.28449580 |
| 174 | histone H4-K12 acetylation (GO:0043983) | 2.28101042 |
| 175 | positive regulation of protein dephosphorylation (GO:0035307) | 2.27881430 |
| 176 | amino sugar catabolic process (GO:0046348) | 2.27874629 |
| 177 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.27842512 |
| 178 | membrane hyperpolarization (GO:0060081) | 2.26999040 |
| 179 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.26923070 |
| 180 | histone H4-K5 acetylation (GO:0043981) | 2.26000516 |
| 181 | histone H4-K8 acetylation (GO:0043982) | 2.26000516 |
| 182 | stress granule assembly (GO:0034063) | 2.25869302 |
| 183 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.24457258 |
| 184 | L-phenylalanine metabolic process (GO:0006558) | 2.24457258 |
| 185 | respiratory burst (GO:0045730) | 2.24347831 |
| 186 | regulation of Rap GTPase activity (GO:0032317) | 2.24326221 |
| 187 | intestinal epithelial cell development (GO:0060576) | 2.23740518 |
| 188 | cortical cytoskeleton organization (GO:0030865) | 2.23327082 |
| 189 | potassium ion import (GO:0010107) | 2.23321946 |
| 190 | cellular sodium ion homeostasis (GO:0006883) | 2.22887216 |
| 191 | adenosine receptor signaling pathway (GO:0001973) | 2.22649814 |
| 192 | regulation of superoxide anion generation (GO:0032928) | 2.22039726 |
| 193 | dicarboxylic acid catabolic process (GO:0043649) | 2.21560866 |
| 194 | serine family amino acid catabolic process (GO:0009071) | 2.21461409 |
| 195 | regulation of bile acid biosynthetic process (GO:0070857) | 2.21103727 |
| 196 | phagocytosis (GO:0006909) | 2.20351128 |
| 197 | activation of JUN kinase activity (GO:0007257) | 2.18173525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 3.52263590 |
| 2 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.16022986 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.92114901 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.83932013 |
| 5 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.68757196 |
| 6 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.62284943 |
| 7 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.57271733 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.55751288 |
| 9 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.43410334 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.38341899 |
| 11 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.31725444 |
| 12 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 2.26993474 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.26440911 |
| 14 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.25393064 |
| 15 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.25393064 |
| 16 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.25393064 |
| 17 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.21937889 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.21003798 |
| 19 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.19021013 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18805868 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.09900092 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09522749 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.05492576 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.04616875 |
| 25 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.03381327 |
| 26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.95551499 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.91559257 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.91203495 |
| 29 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.89509779 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.89020902 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88887802 |
| 32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85307131 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.84784975 |
| 34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.84616893 |
| 35 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.83644498 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83317461 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.82410805 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.80802673 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80641435 |
| 40 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77951660 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.76646326 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.72462329 |
| 43 | MAF_26560356_Chip-Seq_TH1_Human | 1.71362790 |
| 44 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.69543288 |
| 45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.69086680 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.67657304 |
| 47 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66488585 |
| 48 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64522490 |
| 49 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61927116 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61524832 |
| 51 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.61105711 |
| 52 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.59666658 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57413472 |
| 54 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.56760282 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.56496282 |
| 56 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.55085431 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.54906695 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54275688 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54100408 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53868308 |
| 61 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.53642975 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.52360798 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50038674 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49922744 |
| 65 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48628430 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48475215 |
| 67 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.45372909 |
| 68 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43364426 |
| 69 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.42721858 |
| 70 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40756836 |
| 71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.38659287 |
| 72 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38193734 |
| 73 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37320377 |
| 74 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37283783 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37128595 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.36899828 |
| 77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.36719367 |
| 78 | MAF_26560356_Chip-Seq_TH2_Human | 1.35804429 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34873357 |
| 80 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.34368971 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34033762 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33961819 |
| 83 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32766137 |
| 84 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32329748 |
| 85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.32072573 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31701119 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31352309 |
| 88 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28594166 |
| 89 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.27914273 |
| 90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27797328 |
| 91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.27765024 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.27098011 |
| 93 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26984220 |
| 94 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24962549 |
| 95 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23876777 |
| 96 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.22999029 |
| 97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22578059 |
| 98 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.22290412 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22237264 |
| 100 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.22200540 |
| 101 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21409480 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20792941 |
| 103 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20389176 |
| 104 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20327301 |
| 105 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.20083910 |
| 106 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19882540 |
| 107 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.19276243 |
| 108 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.19179893 |
| 109 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19071393 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18896879 |
| 111 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17505528 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16979515 |
| 113 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16597292 |
| 114 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16446799 |
| 115 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.15885225 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15618320 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14954632 |
| 118 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14549310 |
| 119 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13888013 |
| 120 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12287024 |
| 121 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.11770362 |
| 122 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11333749 |
| 123 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.11283347 |
| 124 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.11171468 |
| 125 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11146312 |
| 126 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.10927947 |
| 127 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.10426128 |
| 128 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.10347984 |
| 129 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10082869 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09839060 |
| 131 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.09799411 |
| 132 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09787288 |
| 133 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09213308 |
| 134 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09172085 |
| 135 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09035507 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08516987 |
| 137 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08242501 |
| 138 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06942239 |
| 139 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06408132 |
| 140 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.06236467 |
| 141 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.05837303 |
| 142 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.05564077 |
| 143 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04723667 |
| 144 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03853274 |
| 145 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03169826 |
| 146 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02862670 |
| 147 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02357945 |
| 148 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02286221 |
| 149 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01539574 |
| 150 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01471767 |
| 151 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01332349 |
| 152 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.01180300 |
| 153 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00744026 |
| 154 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00056460 |
| 155 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00042876 |
| 156 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00036886 |
| 157 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.98241123 |
| 158 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98184865 |
| 159 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98122091 |
| 160 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96636772 |
| 161 | AR_19668381_ChIP-Seq_PC3_Human | 0.95723244 |
| 162 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94588857 |
| 163 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94528060 |
| 164 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.94484858 |
| 165 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93856690 |
| 166 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92436295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.44816404 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 3.52843468 |
| 3 | MP0005360_urolithiasis | 3.52592905 |
| 4 | MP0002822_catalepsy | 3.28472805 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.27651321 |
| 6 | MP0003436_decreased_susceptibility_to | 3.23424409 |
| 7 | MP0003303_peritoneal_inflammation | 3.09580022 |
| 8 | MP0004885_abnormal_endolymph | 2.72820184 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.71661116 |
| 10 | MP0004270_analgesia | 2.57568299 |
| 11 | MP0008260_abnormal_autophagy | 2.56519103 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.49230645 |
| 13 | MP0005451_abnormal_body_composition | 2.43848939 |
| 14 | MP0002254_reproductive_system_inflammat | 2.41796067 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.38938525 |
| 16 | MP0003252_abnormal_bile_duct | 2.38618265 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.19708332 |
| 18 | MP0002419_abnormal_innate_immunity | 2.16483448 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.14165616 |
| 20 | MP0002064_seizures | 2.09224025 |
| 21 | MP0005167_abnormal_blood-brain_barrier | 2.09187295 |
| 22 | MP0009745_abnormal_behavioral_response | 2.08994639 |
| 23 | MP0001958_emphysema | 2.03277002 |
| 24 | MP0003724_increased_susceptibility_to | 2.02377097 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.97937886 |
| 26 | MP0004858_abnormal_nervous_system | 1.97335464 |
| 27 | MP0009046_muscle_twitch | 1.95719141 |
| 28 | MP0004947_skin_inflammation | 1.95145075 |
| 29 | MP0003283_abnormal_digestive_organ | 1.90871873 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.90495182 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.90099531 |
| 32 | MP0004510_myositis | 1.89659679 |
| 33 | MP0003329_amyloid_beta_deposits | 1.85697962 |
| 34 | MP0005025_abnormal_response_to | 1.85207106 |
| 35 | MP0003279_aneurysm | 1.85204673 |
| 36 | MP0000685_abnormal_immune_system | 1.85148867 |
| 37 | MP0005377_hearing/vestibular/ear_phenot | 1.84556383 |
| 38 | MP0003878_abnormal_ear_physiology | 1.84556383 |
| 39 | MP0002063_abnormal_learning/memory/cond | 1.83354478 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.82118457 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.80493783 |
| 42 | MP0006082_CNS_inflammation | 1.79835380 |
| 43 | MP0009840_abnormal_foam_cell | 1.79603482 |
| 44 | MP0005365_abnormal_bile_salt | 1.78402486 |
| 45 | MP0005387_immune_system_phenotype | 1.76410967 |
| 46 | MP0001790_abnormal_immune_system | 1.76410967 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.76134839 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.74708400 |
| 49 | MP0003075_altered_response_to | 1.72989186 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.70398047 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.70029933 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.68940336 |
| 53 | MP0005083_abnormal_biliary_tract | 1.68889082 |
| 54 | MP0000858_altered_metastatic_potential | 1.68064490 |
| 55 | MP0005409_darkened_coat_color | 1.65365299 |
| 56 | MP0003632_abnormal_nervous_system | 1.63757173 |
| 57 | MP0001486_abnormal_startle_reflex | 1.62864990 |
| 58 | MP0003828_pulmonary_edema | 1.61216449 |
| 59 | MP0002733_abnormal_thermal_nociception | 1.60775272 |
| 60 | MP0003690_abnormal_glial_cell | 1.60562875 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.60261911 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.57159875 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.56824776 |
| 64 | MP0003787_abnormal_imprinting | 1.55654255 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.55160594 |
| 66 | MP0000569_abnormal_digit_pigmentation | 1.53450469 |
| 67 | MP0002272_abnormal_nervous_system | 1.52600451 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 1.49015617 |
| 69 | MP0002452_abnormal_antigen_presenting | 1.46769716 |
| 70 | MP0002572_abnormal_emotion/affect_behav | 1.46334660 |
| 71 | MP0002734_abnormal_mechanical_nocicepti | 1.45435356 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 1.44781175 |
| 73 | MP0001968_abnormal_touch/_nociception | 1.44252946 |
| 74 | MP0001666_abnormal_nutrient_absorption | 1.43459155 |
| 75 | MP0005332_abnormal_amino_acid | 1.43226489 |
| 76 | MP0002735_abnormal_chemical_nociception | 1.42308476 |
| 77 | MP0009785_altered_susceptibility_to | 1.42202467 |
| 78 | MP0008872_abnormal_physiological_respon | 1.40828998 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.40436749 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 1.39702381 |
| 81 | MP0002723_abnormal_immune_serum | 1.38797913 |
| 82 | MP0002420_abnormal_adaptive_immunity | 1.38627186 |
| 83 | MP0001819_abnormal_immune_cell | 1.38277826 |
| 84 | MP0005423_abnormal_somatic_nervous | 1.34549504 |
| 85 | MP0002653_abnormal_ependyma_morphology | 1.33800997 |
| 86 | MP0001800_abnormal_humoral_immune | 1.33201724 |
| 87 | MP0003633_abnormal_nervous_system | 1.30973933 |
| 88 | MP0005023_abnormal_wound_healing | 1.30711340 |
| 89 | MP0002928_abnormal_bile_duct | 1.30506539 |
| 90 | MP0003631_nervous_system_phenotype | 1.29933369 |
| 91 | MP0003045_fibrosis | 1.29912713 |
| 92 | MP0010155_abnormal_intestine_physiology | 1.29125489 |
| 93 | MP0005671_abnormal_response_to | 1.27136993 |
| 94 | MP0005397_hematopoietic_system_phenotyp | 1.25577442 |
| 95 | MP0001545_abnormal_hematopoietic_system | 1.25577442 |
| 96 | MP0005166_decreased_susceptibility_to | 1.25313386 |
| 97 | MP0003566_abnormal_cell_adhesion | 1.22830094 |
| 98 | * MP0004264_abnormal_extraembryonic_tissu | 1.21416624 |
| 99 | MP0000343_altered_response_to | 1.20516372 |
| 100 | MP0004043_abnormal_pH_regulation | 1.19953520 |
| 101 | MP0000955_abnormal_spinal_cord | 1.19721311 |
| 102 | MP0002405_respiratory_system_inflammati | 1.16767183 |
| 103 | MP0003183_abnormal_peptide_metabolism | 1.15055027 |
| 104 | MP0001501_abnormal_sleep_pattern | 1.14476756 |
| 105 | MP0003868_abnormal_feces_composition | 1.14281686 |
| 106 | MP0003763_abnormal_thymus_physiology | 1.13433269 |
| 107 | MP0001970_abnormal_pain_threshold | 1.13201263 |
| 108 | MP0003448_altered_tumor_morphology | 1.13186717 |
| 109 | MP0000678_abnormal_parathyroid_gland | 1.12750543 |
| 110 | MP0003119_abnormal_digestive_system | 1.11055699 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 1.10842227 |
| 112 | MP0005257_abnormal_intraocular_pressure | 1.10417508 |
| 113 | MP0001849_ear_inflammation | 1.09421456 |
| 114 | MP0000537_abnormal_urethra_morphology | 1.09291244 |
| 115 | MP0002736_abnormal_nociception_after | 1.08535557 |
| 116 | MP0001348_abnormal_lacrimal_gland | 1.06814793 |
| 117 | MP0001845_abnormal_inflammatory_respons | 1.06684519 |
| 118 | MP0004811_abnormal_neuron_physiology | 1.06043941 |
| 119 | MP0001853_heart_inflammation | 1.05680260 |
| 120 | MP0001851_eye_inflammation | 1.04992118 |
| 121 | MP0002067_abnormal_sensory_capabilities | 1.04241442 |
| 122 | MP0000767_abnormal_smooth_muscle | 1.04084781 |
| 123 | MP0004924_abnormal_behavior | 1.03571018 |
| 124 | MP0005386_behavior/neurological_phenoty | 1.03571018 |
| 125 | MP0000751_myopathy | 1.03279502 |
| 126 | MP0008569_lethality_at_weaning | 1.03038396 |
| 127 | MP0005390_skeleton_phenotype | 1.02649398 |
| 128 | MP0004272_abnormal_basement_membrane | 1.02321964 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 1.01570389 |
| 130 | MP0004147_increased_porphyrin_level | 1.01301398 |
| 131 | MP0000716_abnormal_immune_system | 1.01182021 |
| 132 | MP0003880_abnormal_central_pattern | 0.98751056 |
| 133 | MP0004133_heterotaxia | 0.98742969 |
| 134 | MP0010678_abnormal_skin_adnexa | 0.97479415 |
| 135 | MP0002398_abnormal_bone_marrow | 0.96109872 |
| 136 | * MP0002118_abnormal_lipid_homeostasis | 0.94866826 |
| 137 | MP0003191_abnormal_cellular_cholesterol | 0.94852065 |
| 138 | MP0008874_decreased_physiological_sensi | 0.93863702 |
| 139 | MP0000604_amyloidosis | 0.93408205 |
| 140 | MP0002933_joint_inflammation | 0.93321003 |
| 141 | MP0008469_abnormal_protein_level | 0.92543065 |
| 142 | * MP0002152_abnormal_brain_morphology | 0.91079567 |
| 143 | MP0000920_abnormal_myelination | 0.88341481 |
| 144 | MP0002060_abnormal_skin_morphology | 0.88197235 |
| 145 | MP0000249_abnormal_blood_vessel | 0.87837699 |
| 146 | * MP0002066_abnormal_motor_capabilities/c | 0.87156106 |
| 147 | * MP0000778_abnormal_nervous_system | 0.86705374 |
| 148 | MP0005164_abnormal_response_to | 0.86394541 |
| 149 | MP0000465_gastrointestinal_hemorrhage | 0.86290360 |
| 150 | MP0008004_abnormal_stomach_pH | 0.85824314 |
| 151 | MP0002429_abnormal_blood_cell | 0.85674315 |
| 152 | MP0003795_abnormal_bone_structure | 0.83935275 |
| 153 | MP0002168_other_aberrant_phenotype | 0.83893952 |
| 154 | MP0005310_abnormal_salivary_gland | 0.83535016 |
| 155 | MP0004883_abnormal_blood_vessel | 0.82881682 |
| 156 | MP0009278_abnormal_bone_marrow | 0.82678691 |
| 157 | MP0002896_abnormal_bone_mineralization | 0.80880913 |
| 158 | MP0009643_abnormal_urine_homeostasis | 0.80347764 |
| 159 | MP0005666_abnormal_adipose_tissue | 0.79957354 |
| 160 | * MP0002086_abnormal_extraembryonic_tissu | 0.79178182 |
| 161 | MP0003656_abnormal_erythrocyte_physiolo | 0.78578146 |
| 162 | MP0003634_abnormal_glial_cell | 0.78377696 |
| 163 | MP0002722_abnormal_immune_system | 0.77949025 |
| 164 | MP0005165_increased_susceptibility_to | 0.77653278 |
| 165 | MP0005623_abnormal_meninges_morphology | 0.77609786 |
| 166 | MP0002796_impaired_skin_barrier | 0.77282125 |
| 167 | MP0003866_abnormal_defecation | 0.76639583 |
| 168 | MP0005621_abnormal_cell_physiology | 0.76034979 |
| 169 | MP0002557_abnormal_social/conspecific_i | 0.75924873 |
| 170 | MP0005375_adipose_tissue_phenotype | 0.75834751 |
| 171 | MP0003879_abnormal_hair_cell | 0.75446009 |
| 172 | MP0000462_abnormal_digestive_system | 0.74655943 |
| 173 | MP0005076_abnormal_cell_differentiation | 0.74424062 |
| 174 | MP0002069_abnormal_eating/drinking_beha | 0.73227169 |
| 175 | MP0003091_abnormal_cell_migration | 0.73181573 |
| 176 | MP0004808_abnormal_hematopoietic_stem | 0.72944642 |
| 177 | * MP0002882_abnormal_neuron_morphology | 0.70680296 |
| 178 | MP0005670_abnormal_white_adipose | 0.70084962 |
| 179 | * MP0002229_neurodegeneration | 0.69823525 |
| 180 | MP0001664_abnormal_digestion | 0.69798548 |
| 181 | MP0002909_abnormal_adrenal_gland | 0.69180632 |
| 182 | MP0001756_abnormal_urination | 0.68237663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.85702419 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 3.52116604 |
| 3 | Abnormality of the astrocytes (HP:0100707) | 3.49985991 |
| 4 | Astrocytoma (HP:0009592) | 3.49985991 |
| 5 | Abnormality of macrophages (HP:0004311) | 3.41829046 |
| 6 | Focal seizures (HP:0007359) | 3.39789646 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15970706 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.15970706 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.15970706 |
| 10 | Ependymoma (HP:0002888) | 3.14022945 |
| 11 | Abnormality of the corticospinal tract (HP:0002492) | 3.06511427 |
| 12 | Recurrent abscess formation (HP:0002722) | 3.01088805 |
| 13 | Hemiplegia (HP:0002301) | 2.98925535 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 2.92539203 |
| 15 | Glioma (HP:0009733) | 2.83050657 |
| 16 | Dysostosis multiplex (HP:0000943) | 2.81814271 |
| 17 | Protrusio acetabuli (HP:0003179) | 2.79597018 |
| 18 | Increased circulating renin level (HP:0000848) | 2.76068280 |
| 19 | Increased connective tissue (HP:0009025) | 2.75908177 |
| 20 | Hand muscle atrophy (HP:0009130) | 2.75440259 |
| 21 | Ankle clonus (HP:0011448) | 2.74476430 |
| 22 | Increased cerebral lipofuscin (HP:0011813) | 2.71815285 |
| 23 | Premature rupture of membranes (HP:0001788) | 2.71690595 |
| 24 | Metabolic alkalosis (HP:0200114) | 2.70142410 |
| 25 | Postural instability (HP:0002172) | 2.67766662 |
| 26 | Cellulitis (HP:0100658) | 2.66377621 |
| 27 | Vertebral compression fractures (HP:0002953) | 2.64382593 |
| 28 | Myokymia (HP:0002411) | 2.63087038 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 2.62974889 |
| 30 | Impaired social interactions (HP:0000735) | 2.61946981 |
| 31 | Abnormal social behavior (HP:0012433) | 2.61946981 |
| 32 | Distal upper limb amyotrophy (HP:0007149) | 2.57411135 |
| 33 | Upper limb amyotrophy (HP:0009129) | 2.57411135 |
| 34 | Focal motor seizures (HP:0011153) | 2.57134859 |
| 35 | Broad face (HP:0000283) | 2.56568110 |
| 36 | Distal lower limb amyotrophy (HP:0008944) | 2.55369340 |
| 37 | Systemic lupus erythematosus (HP:0002725) | 2.53627876 |
| 38 | Supranuclear gaze palsy (HP:0000605) | 2.53303738 |
| 39 | Spastic gait (HP:0002064) | 2.52334688 |
| 40 | Cerebral inclusion bodies (HP:0100314) | 2.47527318 |
| 41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.46691646 |
| 42 | Urinary urgency (HP:0000012) | 2.46427163 |
| 43 | Status epilepticus (HP:0002133) | 2.45681123 |
| 44 | Obstructive sleep apnea (HP:0002870) | 2.43180241 |
| 45 | Pseudobulbar signs (HP:0002200) | 2.43103648 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39662674 |
| 47 | Gout (HP:0001997) | 2.39311491 |
| 48 | Loss of speech (HP:0002371) | 2.37655253 |
| 49 | Gingivitis (HP:0000230) | 2.37276765 |
| 50 | Spastic tetraparesis (HP:0001285) | 2.36044996 |
| 51 | Amyloidosis (HP:0011034) | 2.35496386 |
| 52 | Visual hallucinations (HP:0002367) | 2.34589502 |
| 53 | Stomach cancer (HP:0012126) | 2.32464431 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32416493 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32416493 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32416493 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28181953 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.28181953 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.28092434 |
| 60 | Hyperglycinuria (HP:0003108) | 2.26828146 |
| 61 | Cervical subluxation (HP:0003308) | 2.24552753 |
| 62 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.24133707 |
| 63 | Polygenic inheritance (HP:0010982) | 2.23175294 |
| 64 | Turricephaly (HP:0000262) | 2.22880594 |
| 65 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.20729524 |
| 66 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.19759877 |
| 67 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.19375860 |
| 68 | Axonal loss (HP:0003447) | 2.17860583 |
| 69 | Termporal pattern (HP:0011008) | 2.17636827 |
| 70 | Insidious onset (HP:0003587) | 2.17636827 |
| 71 | Increased variability in muscle fiber diameter (HP:0003557) | 2.16934171 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16624080 |
| 73 | Myositis (HP:0100614) | 2.16016194 |
| 74 | Abnormality of the labia minora (HP:0012880) | 2.14263634 |
| 75 | Neoplasm of the oral cavity (HP:0100649) | 2.14047777 |
| 76 | Thin bony cortex (HP:0002753) | 2.13362349 |
| 77 | Confusion (HP:0001289) | 2.13207588 |
| 78 | Intrahepatic cholestasis (HP:0001406) | 2.13086393 |
| 79 | Spastic diplegia (HP:0001264) | 2.10972348 |
| 80 | Myocardial infarction (HP:0001658) | 2.09836654 |
| 81 | Neuronal loss in central nervous system (HP:0002529) | 2.05178605 |
| 82 | Esophageal atresia (HP:0002032) | 2.04198309 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.04097867 |
| 84 | Hyperactive renin-angiotensin system (HP:0000841) | 2.03182008 |
| 85 | Action tremor (HP:0002345) | 2.01988428 |
| 86 | Obstructive lung disease (HP:0006536) | 2.01908533 |
| 87 | Chronic obstructive pulmonary disease (HP:0006510) | 2.01908533 |
| 88 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.01849987 |
| 89 | Atrophic scars (HP:0001075) | 2.01198120 |
| 90 | Insomnia (HP:0100785) | 2.00840950 |
| 91 | Colitis (HP:0002583) | 1.99848848 |
| 92 | Dilatation of the ascending aorta (HP:0005111) | 1.99319754 |
| 93 | Fragile skin (HP:0001030) | 1.99009917 |
| 94 | Increased IgE level (HP:0003212) | 1.98800462 |
| 95 | Difficulty climbing stairs (HP:0003551) | 1.98599790 |
| 96 | Disproportionate tall stature (HP:0001519) | 1.98019561 |
| 97 | Xanthomatosis (HP:0000991) | 1.98017978 |
| 98 | Epidermoid cyst (HP:0200040) | 1.97187863 |
| 99 | Abnormality of binocular vision (HP:0011514) | 1.96610831 |
| 100 | Diplopia (HP:0000651) | 1.96610831 |
| 101 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.96482256 |
| 102 | Poor eye contact (HP:0000817) | 1.96342167 |
| 103 | Asymmetric septal hypertrophy (HP:0001670) | 1.95640749 |
| 104 | Achilles tendon contracture (HP:0001771) | 1.94485036 |
| 105 | Hemorrhage of the eye (HP:0011885) | 1.93554055 |
| 106 | Hypokalemic alkalosis (HP:0001949) | 1.93512382 |
| 107 | Elfin facies (HP:0004428) | 1.93080662 |
| 108 | Vacuolated lymphocytes (HP:0001922) | 1.92012406 |
| 109 | Clonus (HP:0002169) | 1.91333992 |
| 110 | Abnormality of glycine metabolism (HP:0010895) | 1.91166584 |
| 111 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.91166584 |
| 112 | Neurofibrillary tangles (HP:0002185) | 1.91008122 |
| 113 | Orchitis (HP:0100796) | 1.89811787 |
| 114 | Aneurysm (HP:0002617) | 1.89519413 |
| 115 | Dysmetria (HP:0001310) | 1.89390474 |
| 116 | Resting tremor (HP:0002322) | 1.88504809 |
| 117 | Renal salt wasting (HP:0000127) | 1.88476987 |
| 118 | Dysdiadochokinesis (HP:0002075) | 1.88168602 |
| 119 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.87808015 |
| 120 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.87808015 |
| 121 | Recurrent skin infections (HP:0001581) | 1.87287399 |
| 122 | Tetraplegia (HP:0002445) | 1.86708122 |
| 123 | Emphysema (HP:0002097) | 1.86177793 |
| 124 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85853379 |
| 125 | Urethral obstruction (HP:0000796) | 1.85852638 |
| 126 | Epileptic encephalopathy (HP:0200134) | 1.84574414 |
| 127 | Gastrointestinal inflammation (HP:0004386) | 1.84264632 |
| 128 | Febrile seizures (HP:0002373) | 1.83660768 |
| 129 | Neoplasm of the adrenal cortex (HP:0100641) | 1.83611478 |
| 130 | Lower limb muscle weakness (HP:0007340) | 1.83093576 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82823223 |
| 132 | Osteolytic defects of the hand bones (HP:0009699) | 1.82823223 |
| 133 | Dysmetric saccades (HP:0000641) | 1.81367096 |
| 134 | Polycythemia (HP:0001901) | 1.81032693 |
| 135 | Nuclear cataract (HP:0100018) | 1.80879399 |
| 136 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.80654911 |
| 137 | Purpura (HP:0000979) | 1.80392961 |
| 138 | Ulnar bowing (HP:0003031) | 1.80289119 |
| 139 | * Spastic paraplegia (HP:0001258) | 1.79369323 |
| 140 | Lower limb amyotrophy (HP:0007210) | 1.78268778 |
| 141 | Vertebral clefting (HP:0008428) | 1.77828511 |
| 142 | Recurrent fungal infections (HP:0002841) | 1.77341535 |
| 143 | Malnutrition (HP:0004395) | 1.76379057 |
| 144 | Cerebral aneurysm (HP:0004944) | 1.76222348 |
| 145 | Hypomagnesemia (HP:0002917) | 1.76058152 |
| 146 | Retinal atrophy (HP:0001105) | 1.75616467 |
| 147 | Blue sclerae (HP:0000592) | 1.74682361 |
| 148 | Hyperacusis (HP:0010780) | 1.74611963 |
| 149 | Onion bulb formation (HP:0003383) | 1.74336266 |
| 150 | Spondylolisthesis (HP:0003302) | 1.74274236 |
| 151 | Partial agenesis of the corpus callosum (HP:0001338) | 1.73281701 |
| 152 | Hepatoblastoma (HP:0002884) | 1.72757344 |
| 153 | Hyperventilation (HP:0002883) | 1.72537807 |
| 154 | Bradykinesia (HP:0002067) | 1.72199723 |
| 155 | Apathy (HP:0000741) | 1.71359888 |
| 156 | Spinal rigidity (HP:0003306) | 1.71196795 |
| 157 | Hemiparesis (HP:0001269) | 1.71114216 |
| 158 | Epistaxis (HP:0000421) | 1.70342172 |
| 159 | Hypertriglyceridemia (HP:0002155) | 1.70278447 |
| 160 | Inflammation of the large intestine (HP:0002037) | 1.70179300 |
| 161 | Flat acetabular roof (HP:0003180) | 1.70098401 |
| 162 | Abnormality of the thoracic spine (HP:0100711) | 1.69754090 |
| 163 | Abnormality of the nasal mucosa (HP:0000433) | 1.69731049 |
| 164 | Arterial tortuosity (HP:0005116) | 1.69610540 |
| 165 | Premature loss of primary teeth (HP:0006323) | 1.69537737 |
| 166 | Abnormality of the Achilles tendon (HP:0005109) | 1.69335551 |
| 167 | Macroorchidism (HP:0000053) | 1.69300537 |
| 168 | Shallow orbits (HP:0000586) | 1.68933710 |
| 169 | Atonic seizures (HP:0010819) | 1.68242177 |
| 170 | Gastrointestinal stroma tumor (HP:0100723) | 1.68175423 |
| 171 | J-shaped sella turcica (HP:0002680) | 1.67897207 |
| 172 | Progressive cerebellar ataxia (HP:0002073) | 1.67861711 |
| 173 | Meningitis (HP:0001287) | 1.67540858 |
| 174 | Joint stiffness (HP:0001387) | 1.67301469 |
| 175 | Thoracic kyphosis (HP:0002942) | 1.67228903 |
| 176 | Abnormal eating behavior (HP:0100738) | 1.66956339 |
| 177 | Pustule (HP:0200039) | 1.66864908 |
| 178 | Peritonitis (HP:0002586) | 1.66833249 |
| 179 | Slow saccadic eye movements (HP:0000514) | 1.66753975 |
| 180 | Vascular tortuosity (HP:0004948) | 1.66537331 |
| 181 | Hepatosplenomegaly (HP:0001433) | 1.66066672 |
| 182 | Pointed chin (HP:0000307) | 1.65745508 |
| 183 | Heterotopia (HP:0002282) | 1.65372506 |
| 184 | * Intention tremor (HP:0002080) | 1.65102824 |
| 185 | Back pain (HP:0003418) | 1.64916398 |
| 186 | Impaired smooth pursuit (HP:0007772) | 1.63793393 |
| 187 | Abnormality of proline metabolism (HP:0010907) | 1.63154297 |
| 188 | Hydroxyprolinuria (HP:0003080) | 1.63154297 |
| 189 | Genetic anticipation (HP:0003743) | 1.62925986 |
| 190 | Hyperaldosteronism (HP:0000859) | 1.62734401 |
| 191 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.62197423 |
| 192 | Impaired vibratory sensation (HP:0002495) | 1.60586117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.48703509 |
| 2 | EPHA2 | 3.44952970 |
| 3 | MAP3K9 | 2.95607221 |
| 4 | SMG1 | 2.70123070 |
| 5 | EPHA4 | 2.50989166 |
| 6 | RIPK4 | 2.49022650 |
| 7 | MAP2K3 | 2.36708367 |
| 8 | PNCK | 2.35100794 |
| 9 | NTRK3 | 2.22722821 |
| 10 | TTN | 2.19368160 |
| 11 | SIK2 | 2.16615070 |
| 12 | BRD4 | 2.12664616 |
| 13 | KSR2 | 2.10415746 |
| 14 | MAP4K1 | 2.09890644 |
| 15 | TYRO3 | 1.98434077 |
| 16 | AKT3 | 1.91515680 |
| 17 | CAMK1G | 1.90486911 |
| 18 | PAK6 | 1.90234759 |
| 19 | NTRK1 | 1.90001762 |
| 20 | IRAK3 | 1.86156266 |
| 21 | STK38 | 1.82702462 |
| 22 | BLK | 1.82000982 |
| 23 | SGK3 | 1.69943774 |
| 24 | TYK2 | 1.69771332 |
| 25 | MAP3K13 | 1.68522509 |
| 26 | MAP3K3 | 1.67813658 |
| 27 | ALK | 1.65297932 |
| 28 | MAP3K11 | 1.59325293 |
| 29 | CAMK1D | 1.54850657 |
| 30 | MAP3K4 | 1.48516297 |
| 31 | MAP3K7 | 1.47398569 |
| 32 | LATS2 | 1.46891507 |
| 33 | DAPK2 | 1.46832538 |
| 34 | WNK1 | 1.46153921 |
| 35 | TAOK2 | 1.45464467 |
| 36 | ZAP70 | 1.45184723 |
| 37 | ARAF | 1.44156607 |
| 38 | MARK1 | 1.41517049 |
| 39 | CSK | 1.35217117 |
| 40 | MAP3K1 | 1.34376197 |
| 41 | OXSR1 | 1.33676791 |
| 42 | WNK3 | 1.32610271 |
| 43 | SIK1 | 1.32215661 |
| 44 | RIPK1 | 1.31879955 |
| 45 | NEK1 | 1.29802946 |
| 46 | MAP3K2 | 1.29218614 |
| 47 | PRKD2 | 1.28311163 |
| 48 | SGK223 | 1.23794265 |
| 49 | SGK494 | 1.23794265 |
| 50 | TBK1 | 1.23726689 |
| 51 | NTRK2 | 1.22926291 |
| 52 | NME2 | 1.22436010 |
| 53 | FES | 1.21009605 |
| 54 | FGFR2 | 1.19660797 |
| 55 | ICK | 1.19598799 |
| 56 | MINK1 | 1.17557580 |
| 57 | IRAK4 | 1.17295217 |
| 58 | SGK2 | 1.16233014 |
| 59 | TESK1 | 1.15775255 |
| 60 | JAK3 | 1.11214008 |
| 61 | TGFBR2 | 1.11046922 |
| 62 | MAP3K14 | 1.08424884 |
| 63 | MET | 1.07506444 |
| 64 | PRPF4B | 1.05230230 |
| 65 | RPS6KA2 | 1.03642065 |
| 66 | TESK2 | 1.03585885 |
| 67 | EEF2K | 1.01714693 |
| 68 | FER | 1.01574176 |
| 69 | PTK2 | 0.99385469 |
| 70 | MAP3K10 | 0.99156974 |
| 71 | MST1R | 0.98284446 |
| 72 | CSNK1A1L | 0.97821111 |
| 73 | MAP2K4 | 0.96697730 |
| 74 | ERN1 | 0.96035151 |
| 75 | FGFR4 | 0.94647420 |
| 76 | MTOR | 0.94314279 |
| 77 | MAP2K2 | 0.92052189 |
| 78 | MAP3K6 | 0.90640885 |
| 79 | KSR1 | 0.89747270 |
| 80 | FGR | 0.89010438 |
| 81 | MAPK12 | 0.87540771 |
| 82 | PAK3 | 0.87469045 |
| 83 | GRK6 | 0.86708532 |
| 84 | PRKCH | 0.85502721 |
| 85 | PKN2 | 0.85218899 |
| 86 | BTK | 0.83818816 |
| 87 | MARK2 | 0.83168758 |
| 88 | TAOK1 | 0.82870970 |
| 89 | HCK | 0.81369395 |
| 90 | MAPK7 | 0.80672973 |
| 91 | TSSK6 | 0.78499185 |
| 92 | MOS | 0.78266394 |
| 93 | PTK6 | 0.77917531 |
| 94 | TTK | 0.77515160 |
| 95 | CSF1R | 0.77296267 |
| 96 | CDK5 | 0.76682582 |
| 97 | PDK1 | 0.76653520 |
| 98 | PDGFRA | 0.76339518 |
| 99 | RPS6KL1 | 0.75130298 |
| 100 | RPS6KC1 | 0.75130298 |
| 101 | RPS6KB2 | 0.71565354 |
| 102 | EPHB1 | 0.71145834 |
| 103 | HIPK2 | 0.69930863 |
| 104 | MAP2K1 | 0.69571488 |
| 105 | SGK1 | 0.69529452 |
| 106 | MATK | 0.68798616 |
| 107 | PRKCI | 0.68542670 |
| 108 | CDC42BPA | 0.66207175 |
| 109 | RET | 0.64672731 |
| 110 | TNK2 | 0.62790922 |
| 111 | IRAK2 | 0.62544197 |
| 112 | MAP3K8 | 0.62188793 |
| 113 | CAMKK1 | 0.60925246 |
| 114 | BMX | 0.59768157 |
| 115 | CSNK1G2 | 0.58633248 |
| 116 | PIM2 | 0.58500484 |
| 117 | CSNK1D | 0.57764199 |
| 118 | BRAF | 0.55345177 |
| 119 | JAK2 | 0.54235669 |
| 120 | SYK | 0.53797301 |
| 121 | CSNK1E | 0.53247960 |
| 122 | PRKD3 | 0.53215230 |
| 123 | RPS6KA6 | 0.52407730 |
| 124 | TRIB3 | 0.52022469 |
| 125 | PRKCG | 0.51643098 |
| 126 | DAPK1 | 0.51501411 |
| 127 | STK11 | 0.50569676 |
| 128 | NEK9 | 0.50286761 |
| 129 | LRRK2 | 0.50009240 |
| 130 | LMTK2 | 0.49678103 |
| 131 | STK10 | 0.48751067 |
| 132 | NEK6 | 0.48254193 |
| 133 | ERBB2 | 0.48237997 |
| 134 | MAPK10 | 0.47616182 |
| 135 | MAPK11 | 0.46853773 |
| 136 | IKBKE | 0.45524722 |
| 137 | PAK4 | 0.44980504 |
| 138 | GRK5 | 0.44850501 |
| 139 | PDGFRB | 0.43460961 |
| 140 | PINK1 | 0.43216652 |
| 141 | LCK | 0.42937665 |
| 142 | FYN | 0.42216984 |
| 143 | PTK2B | 0.42004629 |
| 144 | CAMK2G | 0.40983547 |
| 145 | DYRK1B | 0.40936730 |
| 146 | AKT2 | 0.40871019 |
| 147 | RPS6KA3 | 0.40694625 |
| 148 | CSNK1A1 | 0.40165781 |
| 149 | PRKAA1 | 0.39907152 |
| 150 | GSK3B | 0.39440713 |
| 151 | MAPK8 | 0.39304751 |
| 152 | JAK1 | 0.38733480 |
| 153 | DDR2 | 0.38712491 |
| 154 | PDPK1 | 0.38363636 |
| 155 | SIK3 | 0.37904667 |
| 156 | LYN | 0.37369230 |
| 157 | SRC | 0.36341740 |
| 158 | PRKG2 | 0.36051554 |
| 159 | LATS1 | 0.33698652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33074551 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.74383698 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.62142475 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.48681038 |
| 5 | Bile secretion_Homo sapiens_hsa04976 | 2.25360046 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.07530727 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05470475 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.04996097 |
| 9 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.04097005 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.87475007 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87447040 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.84145338 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.82215135 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.80438863 |
| 15 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.76163583 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74235684 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68715492 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67550790 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.62712124 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.60469800 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58368499 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53288349 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52632932 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.48567398 |
| 25 | Lysine degradation_Homo sapiens_hsa00310 | 1.47239344 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46590929 |
| 27 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.45409015 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41961515 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.38316948 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37252390 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35979947 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.33255575 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.31999425 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.29500588 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.27773187 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27699510 |
| 37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26922034 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25120928 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.23289449 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.21258548 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20344492 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19497042 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.18963895 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 1.17831716 |
| 45 | Bladder cancer_Homo sapiens_hsa05219 | 1.17718078 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17388466 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.17048222 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.16287546 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15864159 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.15829411 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.15695243 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12433986 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11145809 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09955951 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.09386741 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.08746659 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.07797841 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07358615 |
| 59 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06921445 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.06404600 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04133311 |
| 62 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.03946674 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 1.03829709 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 1.00942612 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 1.00941322 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00057473 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99915031 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.99597682 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99096320 |
| 70 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98838017 |
| 71 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.98422353 |
| 72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.98351399 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97797038 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.96430186 |
| 75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.95389283 |
| 76 | Allograft rejection_Homo sapiens_hsa05330 | 0.94934141 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.94890011 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94833896 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.94223284 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.93285972 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.93252729 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92340769 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92200333 |
| 84 | Hepatitis B_Homo sapiens_hsa05161 | 0.92041875 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91713422 |
| 86 | Platelet activation_Homo sapiens_hsa04611 | 0.91144007 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90822336 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90812522 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90704120 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.90453848 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88816345 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88326151 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88166982 |
| 94 | Insulin secretion_Homo sapiens_hsa04911 | 0.86375220 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84996635 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.84832851 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84083581 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83642677 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83534450 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83480782 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82958637 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82575537 |
| 103 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82053497 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81932397 |
| 105 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81291737 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81245419 |
| 107 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80823010 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79272430 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79255361 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78347822 |
| 111 | Measles_Homo sapiens_hsa05162 | 0.78289652 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.76871836 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76824932 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76649859 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.76520412 |
| 116 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76462974 |
| 117 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.76417176 |
| 118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74788473 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74458712 |
| 120 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74438681 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.73758409 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72750778 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72574321 |
| 124 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72547917 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72242471 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70897809 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70692761 |
| 128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70434415 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.70249690 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70077968 |
| 131 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69919181 |
| 132 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69831579 |
| 133 | Legionellosis_Homo sapiens_hsa05134 | 0.69522951 |
| 134 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69511282 |
| 135 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68479239 |
| 136 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68387568 |
| 137 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68381203 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68049809 |
| 139 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66790057 |
| 140 | Taste transduction_Homo sapiens_hsa04742 | 0.66636688 |
| 141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66303828 |
| 142 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65565081 |
| 143 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.63808990 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.63564872 |
| 145 | Thyroid cancer_Homo sapiens_hsa05216 | 0.63297790 |
| 146 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.62757414 |
| 147 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62083238 |
| 148 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61914380 |
| 149 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61880771 |
| 150 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61834696 |
| 151 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61366420 |
| 152 | Glioma_Homo sapiens_hsa05214 | 0.61286054 |
| 153 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61140190 |
| 154 | Adherens junction_Homo sapiens_hsa04520 | 0.60989636 |
| 155 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.60311385 |
| 156 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59171499 |
| 157 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58877225 |
| 158 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58529275 |
| 159 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58089296 |
| 160 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56824155 |
| 161 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56694246 |
| 162 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55521829 |
| 163 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.55342786 |
| 164 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54808183 |
| 165 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52913869 |
| 166 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52561742 |
| 167 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52429649 |
| 168 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51328228 |
| 169 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51035326 |
| 170 | Axon guidance_Homo sapiens_hsa04360 | 0.51014900 |
| 171 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50789261 |
| 172 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50320476 |
| 173 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50035530 |
| 174 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49558731 |
| 175 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47614900 |
| 176 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47273877 |
| 177 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46876145 |
| 178 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44949219 |
| 179 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44707895 |
| 180 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44202227 |
| 181 | Renin secretion_Homo sapiens_hsa04924 | 0.42292950 |

